Bank Julius Baer & Co
FLGT icon

Bank Julius Baer & Co’s Fulgent Genetics FLGT Stock Holding History

Bank Julius Baer & Co’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-82
Closed -$8K – 651
2021
Q4 		$8K Hold
82
– – ﹤0.01% 792
2021
Q3 		$7K Buy
82
+28
+52% +$2.54K ﹤0.01% 785
2021
Q2 		$5K Sell
54
-290
-84% -$23.2K ﹤0.01% 800
2021
Q1 		$33K Buy
344
+286
+493% +$29.5K ﹤0.01% 712
2020
Q4 		$3K Buy
+58
New +$2.42K ﹤0.01% 787

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank Julius Baer & Co's FLGT Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Fulgent Genetics (FLGT) in Q1 2022, closing a stake of 82 shares — an estimated $8K sold.

Bank Julius Baer & Co first reported a position in FLGT in Q4 2020 and held it in 5 quarters. The position peaked at $33K in Q1 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining Fulgent Genetics position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 82 Fulgent Genetics shares in Q1 2022, an estimated $8K.
  • Bank Julius Baer & Co first reported a position in Fulgent Genetics in Q4 2020 and held it in 5 quarters.
  • Bank Julius Baer & Co's Fulgent Genetics position peaked at $33K in Q1 2021.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.